Clinical trial
A Post Market, Global Registry to Evaluate the Identification of Atrial Fibrillation Sources Using Electrographic Flow (EGF™) Mapping System to Guide Ablation Therapy in Patients With Atrial Fibrillation in Real-world Setting.
NCT05481359 is registered in ClinicalTrials.gov with Ablacon, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post Market, Global Registry to Evaluate the Identification of Atrial Fibrillation Sources Using Electrographic Flow (EGF™) Mapping System to Guide Ablation Therapy in Patients With Atrial Fibrillation in Real-world Setting.
- Lead sponsor
- Ablacon, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 12, 2022
- Completion date
- November 17, 2023
- Enrollment
- 25 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmias, cardiac, atrial fibrillation, atrial fibrillation, persistent, heart diseases